KMT2A and acute myeloid leukemia: Considering the fact that patients with chronic lymphocytic leukemia (CLL) that is sensitive to VEN are dependent on high BCL‐2 expression in CLL cells, VEN may be sensitive to MLL‐rearranged AML.